It was reported that the patient had a small bowel obstruction and went to the operating room (or) where they had jejunum resected and a primary distal jejunum to duodenum anastomosis.The gut was rested for one week but the patient continued to have low hemoglobin requiring regular blood transfusions.Computed tomography (ct) and gastroscopy was performed on (b)(6) 2023 for suspected bleeding and bowel obstruction.On (b)(6) 2023, the patient was taken back to the or for a relook laparotomy.Upon returning from the or, in the cardiovascular intensive care unit (cvicu), the patient had blown pupil and head ct was performed that showed a massive intercranial bleed.Care was withdrawn on (b)(6) 2023 and the patient passed away.
|
Manufacturer's investigation conclusion: a direct correlation between heartmate 3 lvas (left ventricular assist system), serial number (b)(6), and the patient's outcome could not conclusively be determined through this evaluation.Heartmate 3 lvas, serial number (b)(6), was reported to have been operating as intended at the time of the patient's outcome.It was also reported that the device will not be returned for evaluation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviation from manufacturing or quality assurance specifications.The current heartmate 3 left ventricular assist system instructions for use (ifu) contains the following information: section 1 outlines potential adverse events, including thromboembolism, bleeding, stroke, and death that may be associated with the use of heartmate 3 left ventricular assist system.Section 6 lists thromboembolism as a late post-implant complication that may be associated with the use of the heartmate 3 left ventricular assist system.Information regarding recommended anticoagulation therapy and international normalized ratio range is also provided in this section.No further information was provided.The manufacturer is closing the file on this event.
|